
- /
- Supported exchanges
- / US
- / CRHKF.PINK
China Resources Beer Holdings Co Ltd (CRHKF PINK) stock market data APIs
China Resources Beer Holdings Co Ltd Financial Data Overview
China Resources Beer (Holdings) Company Limited, an investment holding company, manufactures, distributes, and sells alcoholic beverages in Mainland China. It offers beer and baijiu products. The company was formerly known as China Resources Enterprise, Limited and changed its name to China Resources Beer (Holdings) Company Limited in October 2015. The company was incorporated in 1965 and is based in Wan Chai, Hong Kong. China Resources Beer (Holdings) Company Limited operates as a subsidiary of CRH (Beer) Limited.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get China Resources Beer Holdings Co Ltd data using free add-ons & libraries
Get China Resources Beer Holdings Co Ltd Fundamental Data
China Resources Beer Holdings Co Ltd Fundamental data includes:
- Net Revenue: 38 635 M
- EBITDA: 7 045 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
Get China Resources Beer Holdings Co Ltd End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
China Resources Beer Holdings Co Ltd News

Trending tickers: Bitcoin, Alibaba, Heineken and Pearson
Bitcoin (BTC-USD) Bitcoin surged to its highest level in six weeks, trading close to the $70,000 mark on Monday, following former US president Donald Trump’s renewed endorsement of cryptocurrency o...


Heineken's shares slide as first-half results miss forecasts
LONDON (Reuters) -Dutch brewer Heineken reported a 12.5% rise in half-year operating profit on Monday after an anticipated boost from sporting events in June and July did not materialise, missing anal...

Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI)
Zealand Pharma Company announcement – No. 4 / 2022 Zealand Pharma Completes Enrollment in Phase 3 Trialof Dasiglucagon in Childrenwith Congenital Hyperinsulinism(CHI) Top-line results expected in...

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Company announcement – No.74 /2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S.December1, 2021 – Zealand Pharm...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.